Application of PET-CT in efficacy evaluation of neoadjuvant chemotherapy for breast cancer
10.3760/cma.j.issn.1006-9801.2014.01.002
- VernacularTitle:PET-CT评价乳腺癌新辅助化疗效果的研究
- Author:
Gang GUO
;
Xiping ZHANG
;
Junjing ZHANG
;
Zhichuan ZHU
;
Haiou LIU
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Neoadjuvant therapy;
Treatment outcome;
Positron-emission tomography;
Computed tomography
- From:
Cancer Research and Clinic
2014;26(1):6-8,12
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the value of PET-CT in patients with breast cancer and to determine if the PET-CT can provide additional information to predict early response to neoadjuvant chemotherapy (NAC).Methods NAC was given to 20 patients with breast cancer confirmed by biopsy puncture from September 2009 to March 2012.The PET-CT was carried out for all patients before NAC.TEC program with three weeks for one cycle was selected.After 6 days of the first cycle,the PET-CT was performed again.The changes of standard uptake value before and after the first cycle were compared.At the same time hand palpation was selected to detect the changes in tumor size before and after the first cycle of NAC.The changes of the standard uptake value and in tumor size need to refer to the pathology Miller & Payne classification methods to evaluate the efficacy of the NAC.Results The SUV were (7.51±1.76) Bq/ml and (4.98±1.61) Bq/ml before and after chemotherapy (t =7.916,P ＜ 0.05) the maximum tumor diameters were (9.62±4.38) cm and (8.89±4.08) cm before and after NAC (t =2.154,P＞ 0.05).SUV had highly correlated with pathological MP classification (r =0.725,P =0.000); while for the tumor size there was no significant change (r =0.026,P =0.824).Conclusion PET-CT can predict the efficacy earlier and is more accurate than clinical efficacy standard for the NAC.
